Price Targets on (AGN) (CBS) (COCO) (CPT) (EXBD) Updated by Analysts

Analysts updated the price targets on Allergan, Inc. (NYSE: AGN), CBS (NYSE: CBS), Corinthian Colleges, Inc. (NASDAQ: COCO), Camden Property Trust (NYSE: CPT) and The Corporate Executive Board Company (NASDAQ: EXBD).

Collins Stewart raised their price target on Allergan, Inc. (AGN) from $75.00 to $85.00. They have a “hold” rating on the company.

Barclays Capital raised their price target on CBS (CBS) from $25.00 to $30.00. They have an “equal weight” rating on the company.

Barclays Capital cut their price target on Corinthian Colleges, Inc. (COCO) from $4.00 to $3.00. They have an “underweight” rating on the company.

Barclays Capital raised their price target on Camden Property Trust (CPT) from $58.00 to $65.00. They have an “overweight” rating on the company.

Barclays Capital raised their price target on The Corporate Executive Board Company (EXBD) from $39.00 to $45.00. They have an “equal weight” rating on the company.

Allergen (NYSE:AGN) Gets Botox Boost

Allergen (NYSE:AGN) is one of Susquehanna's top picks for 2011, based on what they see as an increase in Botox sales.

For 2011 they see sales reaching $15 million; for 2012 Botox sales are expected to climb to $65 million; and for 2013-14, they're estimated to come in at $100 million.

EPS estimates for Allergen in 2012 and 2013 were raised by $0.02, and for 2014 by $0.04. Over the next few years Susquehanna believes Allergen's EPS will grow by close to 15 percent.

Allergen closed Wednesday at $70.72, losing $1.36, or 1.89 percent.